Trial Profile
Safety and Efficacy of Pomalidomide in the Treatment of Refractory Cough in Patients With Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2023
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 10 Apr 2015 New trial record